Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRN.
Atia O, Orlanski-Meyer E, Lujan R, Ledderman N, Greenfeld S, Kariv R, Daher S, Yanai H, Loewenberg Weisband Y, Gabay H, Matz E, Nevo D, Israeli E, Schwartz D, Chowers Y, Dotan I, Turner D. Atia O, et al. Among authors: orlanski meyer e. J Crohns Colitis. 2022 Jun 24;16(5):778-785. doi: 10.1093/ecco-jcc/jjab204. J Crohns Colitis. 2022. PMID: 34791083
Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial.
Turner D, Bishai J, Reshef L, Abitbol G, Focht G, Marcus D, Ledder O, Lev-Tzion R, Orlanski-Meyer E, Yerushalmi B, Aloi M, Griffiths AM, Albenberg L, Kolho KL, Assa A, Cohen S, Gophna U, Vlamakis H, Lurz E, Levine A. Turner D, et al. Inflamm Bowel Dis. 2020 Oct 23;26(11):1733-1742. doi: 10.1093/ibd/izz298. Inflamm Bowel Dis. 2020. PMID: 31833543 Clinical Trial.
Appraisal of the PIBD-classes Criteria: A Multicentre Validation.
Ledder O, Sonnino M, Birimberg-Schwartz L, Escher JC, Russell RK, Orlanski-Meyer E, Matar M, Assa A, Tzion RL, Shteyer E, Griffiths A, Turner D. Ledder O, et al. J Crohns Colitis. 2020 Dec 2;14(12):1672-1679. doi: 10.1093/ecco-jcc/jjaa103. J Crohns Colitis. 2020. PMID: 32453831
Outcomes Following Pouch Formation in Paediatric Ulcerative Colitis: A Study From the Porto Group of ESPGHAN.
Orlanski-Meyer E, Topf-Olivestone C, Ledder O, Dotan I, Folmer-Hansen L, Kindermann A, Assa A, Kolho KL, Kolaček S, Carroll MW, Strisciuglio C, Aloi M, Hansen R, Navon D, Winter HS, Navas-López VM, de Ridder L, Smets F, Weiss B, Turner D. Orlanski-Meyer E, et al. J Pediatr Gastroenterol Nutr. 2020 Sep;71(3):346-353. doi: 10.1097/MPG.0000000000002805. J Pediatr Gastroenterol Nutr. 2020. PMID: 32541197 Free article.
Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.
Ricciuto A, Aardoom M, Orlanski-Meyer E, Navon D, Carman N, Aloi M, Bronsky J, Däbritz J, Dubinsky M, Hussey S, Lewindon P, Martín De Carpi J, Navas-López VM, Orsi M, Ruemmele FM, Russell RK, Veres G, Walters TD, Wilson DC, Kaiser T, de Ridder L, Turner D, Griffiths AM; Pediatric Inflammatory Bowel Disease–Ahead Steering Committee. Ricciuto A, et al. Gastroenterology. 2021 Jan;160(1):403-436.e26. doi: 10.1053/j.gastro.2020.07.065. Epub 2020 Sep 23. Gastroenterology. 2021. PMID: 32979356 Free article.
Monitoring Enables Progress: A Nationwide Quality Improvement Program in Children With Crohn Disease.
Yogev D, Shosberger A, Nehemia C, Harel S, Yerushalmy-Feler A, Ledder O, Orlanski-Meyer E, Assa A, Slae M, Kori M, Elenberg Y, Shaoul R, Zifman E, Shamaly H, Berkowitz D, Sarit P, Yerushalmi B, Broide E, On A, Elkayam O, Bayan H, Gorodnichenko A, Pinsk V, Shouval DS, Turner D. Yogev D, et al. J Pediatr Gastroenterol Nutr. 2021 Aug 1;73(2):236-241. doi: 10.1097/MPG.0000000000003133. J Pediatr Gastroenterol Nutr. 2021. PMID: 33783402
Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN.
Atia O, Orlanski-Meyer E, Lujan R, Ledderman N, Greenfeld S, Kariv R, Daher S, Yanai H, Loewenberg Weisband Y, Gabay H, Matz E, Nevo D, Ollech J, Zittan E, Israeli E, Schwartz D, Chowers Y, Dotan I, Turner D. Atia O, et al. Among authors: orlanski meyer e. J Crohns Colitis. 2022 Jun 24;16(5):796-803. doi: 10.1093/ecco-jcc/jjab210. J Crohns Colitis. 2022. PMID: 34904163
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real-world patient mix.
Atia O, Pujol-Muncunill G, Navas-López VM, Orlanski-Meyer E, Ledder O, Lev-Tzion R, Focht G, Shteyer E, Stein R, Aloi M, Russell RK, Martin-de-Carpi J, Turner D. Atia O, et al. Among authors: orlanski meyer e. Aliment Pharmacol Ther. 2022 Sep;56(5):794-801. doi: 10.1111/apt.17092. Epub 2022 Jun 23. Aliment Pharmacol Ther. 2022. PMID: 35735987 Free PMC article.
23 results